NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Study Comparing Etanercept Plus Methotrexate to Either Etanercept or Methotrexate Alone in Rheumatoid Arthritis.

CompletedPhase 3

Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer

Conditions: Active Rheumatoid Arthritis

Interventions: Etanercept

Countries: Australia, Austria, Belgium, Czechia, Denmark, Finland, France, Germany

To compare the therapeutic and radiographic effects and safety between etanercept, methotrexate, and the etanercept/methotrexate combination in patients with rheumatoid arthritis.

Eligibility overview

Sex: MALE

Age: 18 Years to —

Healthy volunteers: No

Study type: INTERVENTIONAL

Eligibility criteria

Inclusion:

\- Generally healthy of at least 18 years of age with active rheumatoid arthritis.

Exclusion:

\- A history or presence of clinically important medical disease.

Locations (88)

St Leonards, New South Wales, Australia
Adelaide, Australia
Southport, Australia
Vienna, Austria
Brussels, Belgium
Diepenbeek, Belgium
Ghent, Belgium
Leuven, Belgium
Liège, Belgium
Česká Lípa, Czechia
Prague, Czechia
Terezín, Czechia
Zlín, Czechia
Copenhagen, Denmark
Herlev, Denmark
Kuopio, Finland
Rauma, Finland
Tampere, Finland
Vantaa, Finland
Bordeaux, France
Brest, France
Créteil, France
Grenoble, France
Le Kremlin-Bicêtre, France
Montpellier, France
Nice, France
Paris, France
Paris, France
Paris, France
Rouen, France
+ 58 more on CT.gov